A research paper done by a Harvard professor showed the employment rate for women rose by 27% after taking GLP-1s.

In a target trial emulation, getting a COVID and flu shot on the same day was not associated with an increased risk of ...

Women who were vaccinated against covid-19 in the luteal phase of their menstrual cycle reported having a breakthrough ...

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

Pfizer has reported topline data from the Phase III SigVie-002 study investigating sigvotatug vedotin in adults with ...

Pfizer Inc. said an experimental drug failed to improve survival in patients with an advanced form of lung cancer that couldn ...

Pfizer said on Monday that one ‌of the key experimental drugs it picked up in its $43 billion 2023 acquisition of Seagen ...

Pfizer (PFE) stock is in focus as the antibody-drug conjugate sigvotatug vedotin fails in a Phase 3 trial versus chemotherapy ...

Despite an overall survival miss, Leerink Partners said Pfizer’s antibody-drug conjugate showed “promising” signals of efficacy in a subgroup of patients who had undergone only one prior line of ...

Pfizer Inc. is pulling back the curtain on its obesity ambitions, releasing new data on an experimental weight-loss shot and outlining a strategy to claw its way into a leadership position in the ...

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Limited time: Save 25% on NBC News subscription Get exclusive reporting, ...

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...